Johnson & Johnson (JNJ) acquired Auris Health, a surgical robotics firm, in 2019, valuing the surgical device maker at $3.4B.
More on Johnson & Johnson
- Johnson & Johnson (JNJ) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
- Johnson & Johnson: Valuation Premium Justified By Accelerating Growth And Mix Premiumization
- Johnson & Johnson: Quality Compounding, Valuations Now Do The Heavy Lifting
- Johnson & Johnson enters pact with Trump admin for drug discounts
- J&J submits application for FDA approval of OTTAVA robotic surgical system